Cytologic diagnosis of adenocarcinoma in biliary and pancreatic duct brushings

Advances in Anatomic Pathology

Volumn 9, Issue 5, 2002, Pages 301-308

  Henke, Andrew C ^a   Jensen, Chris S ^a   Cohen, Michael B ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Adenocarcinoma; Bile duct; Cholangiocarcinoma; Cytology; Pancreatic duct

Indexed keywords

BILE DUCT CARCINOMA; CYTODIAGNOSIS; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; METHODOLOGY; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PATHOLOGY; REVIEW;

CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOCARCINOMA; CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PANCREATIC DUCTS; PANCREATIC NEOPLASMS;

EID: 85047686922     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200209000-00004     Document Type: Review

References (72)

1. Curley S. Biliary tract cancer. Cancer Treat Res 1997;90:273-307.
2. Chapman R. Risk factors for biliary tract carcinogenesis. Ann Oncol 1999;10(Suppl 4):S308-S311. (Pubitemid 29333457)
3. Jarnagin W. Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol 2000;19:156-176.
4. Parkin D, Ohshima H, Srivatanakul P, Vatanasapt V. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev 1993;2:537-544.
5. Holzinger F, Z'graggen K, Buchler M. Mechanisms of biliary carcinogenesis: a pathogenetic multistage cascade towards cholangiocarcinoma. Ann Oncol 1999;10(Suppl 4):S122-S126. (Pubitemid 29333412)
6. American Gastroenterological Association Clinical Practice and Practice Economics Committee. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999;117:1464-1484.
7. Wanebo H, Vezeridas M. Pancreatic carcinoma in perspective. A continuing challenge. Cancer 1996;78:580-591. (Pubitemid 26251517)
8. Hruban R, Wilentz R, Goggins G, Offerhaus G, Yeo C, Kern S. Pathology of incipient pancreatic cancer. Ann Oncol 1999;10(Suppl 4):S9-S11. (Pubitemid 29333385)
9. Hruban R, Wilentz R, Kern S. Genetic progression in the pancreatic ducts. Am J Pathol 2000;156:1821-1825. (Pubitemid 30641750)
10. Kern S. Molecular genetic alterations in ductal pancreatic adenocarcinomas. Med Clin North Am 2000;84:691-695. (Pubitemid 30346163)
11. Foutch P, Harlan J, Kerr D, Sanowski R. Wire-guided brush cytology: a new endoscopic method for diagnosis of bile duct cancer. Gastrintest Endosc 1989;35:243-247. (Pubitemid 19164893)
12. Bardales R, Stanley M, Simpson D, et al. Diagnostic value of brush cytology in the diagnosis of duodenal, biliary, and ampullary neoplasms. Am J Clin Pathol 1998;109:540-548. (Pubitemid 28191541)
13. Desa L, Akosa A, Lazzara S, Domizio P, Krausz T, Benjamin I. Cytodiagnosis in the management of extrahepatic biliary stricture. Gut 1991;32:1188-1191.
14. Ferrari A, Lichtenstein D, Slivka A, Chang C, Carr-Locke D. Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies. Gastrointest Endosc 1994;40:140-145. (Pubitemid 24129187)
15. Foutch P, Kerr D, Harlan J, Kummet T. A prospective, controlled analysis of endoscopic cytotechniques for diagnosis of malignant biliary strictures. Am J Gastroenterol 1991;86:577-580.
16. Foutch P, Kerr D, Harlan J, Manne K, Kummet T, Sanowski R. Endoscopic retrograde wire-guided brush cytology for diagnosis of patients with malignant obstruction of the bile duct. Am J Gastroenterol 1990;85:791-795. (Pubitemid 20280923)
17. Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, Adler G. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endosc 1999;31:712-717.
18. Kurzawinski T, Deery A, Davidson B. Diagnostic value of cytology for biliary stricture. Br J Surg 1993;80:414-421. (Pubitemid 23116071)
19. Kurzawinski T, Deery A, Dooley J, Dick R, Hobbs K, Davidson B. A prospective study of biliary cytology in 100 patients with bile duct strictures. Hepatology 1993;18:1399-1403. (Pubitemid 23348428)
20. Kurzawinski T, Deery A, Dooley J, Dick R, Hobbs K, Davidson B. A prospective controlled study comparing brush and bile exfoliative cytology for diagnosing bile duct strictures. Gut 1992;33:1675-1677.
21. Lee J, Leung J, Baillie J, Layfield L, Cotton P. Benign, dysplastic, or malignant-making sense of endoscopic bile duct brush cytology: results in 149 consecutive patients. Am J Gastroenterol 1995;90:722-726.
22. Lograno R, Kurtycz D, Molina C, Trivedi V, Wong J, Block K. Analysis of false-negative diagnoses on endoscopic brush cytology of biliary and pancreatic duct strictures. Arch Pathol Lab Med 2000;124:387-392. (Pubitemid 30152140)
23. Mansfield J, Griffin S, Wadehra V, Matthewson K. A prospective evaluation of cytology from biliary strictures. Gut 1997;40:671-677. (Pubitemid 27278338)
24. McGuire D, Venu R, Brown R, Etzkorn K, Glaws W, Abu-Hammour A. Brush cytology for pancreatic carcinoma: an analysis of factors influencing results. Gastrointest Endosc 1996;44:300-304. (Pubitemid 26318332)
25. Ponchon T, Gagnon P, Berger F, et al. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc 1995;42:565-572.
26. Ponsioen C, Vrouenraets S, de Wit A, et al. Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endosc 1999;31:305-309.
27. Pugliese V, Conio M, Nicolo G, Saccomanno S, Gatteschi B. Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc 1995;42:520-526.
28. Rabinovitz M, Zajko A, Hassanein T, et al. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures. Hepatology 1990;12:747-752. (Pubitemid 20349261)
29. Rupp M, Hawthorne C, Ehya H. Brushing cytology in biliary tract obstruction. Acta Cytol 1990;34:221-226. (Pubitemid 20126125)
30. Ryan M. Cytologic brushings of ductal lesions during ERCP. Gastrointest Endosc 1991;37:139-142.
31. Schoefl R, Haefner M, Wrba F, et al. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol 1997;32:363-368. (Pubitemid 27156174)
32. Scudera P, Koizumi J, Jacobson I. Brush cytology of lesions encountered during ERCP. Gastrointest Endosc 1990;36:281-284. (Pubitemid 20180513)
33. Sugiyama M, Atomi Y, Wada N, Kuroda A, Muto T. Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparative study with bile and brush cytology. Am J Gastroenterol 1996;91:465-467. (Pubitemid 26083547)
34. Vandervoort J, Soetikno R, Montes H, et al. Accuracy and complication rate of brush cytology from bile versus pancreatic duct. Gastrointest Endosc 1999;49:322-327. (Pubitemid 29135224)
35. DeMay R. The gastrointestinal tract. In: The Art & Science of Cytopathology. Chicago: ASCP Press; 1996:357-360.
36. Layfield L, Wax T, Lee J, Cotton P. Accuracy and morphologic aspects of pancreatic and biliary duct brushings. Acta Cytol 1995;39;11-18.
37. Cohen M, Wittchow R, Johlin F, Bottles K, Raab S. Brush Cytology of the Extrahepatic Biliary Tract: Comparison of Cytologic Features of Adenocarcinoma and Benign Biliary Strictures. Mod Pathol 1995;8:498-502.
38. Cohen M, Egerter D, Holly E, Ahn D, Miller T. Pancreatic adenocarcinoma: regression analysis to identify improved cytologic criteria. Diag Cytopathol 1991;7:341-345.
39. Mitchell M, Carney C. Cytologic criteria for the diagnosis of pancreatic carcinoma. Am J Clin Pathol 1985;83:171-176. (Pubitemid 15128842)
40. Nakajima T, Tajima Y, Sugano I, et al. Multivariate statistical analysis of bile cytology. Acta Cytol 1994;38:51-55. (Pubitemid 24054080)
41. Renshaw A, Madge R, Jiroutek M, Granter S. Bile duct brush cytology. Statistical analysis of proposed diagnostic criteria. Am J Clin Pathol 1998;110:635-640. (Pubitemid 28491969)
42. Kocjan G, Smith A. Bile duct brushings cytology: potential pitfalls in diagnosis. Diag Cytopathol 1997;16:358-363. (Pubitemid 27197713)
43. Abbruzzese J. Molecular diagnosis of pancreatic and biliary cancer: ready for broad implementation? Cancer J 2000;6:282-284.
44. Bramhall S. The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis. Int J Pancreatol 1998;23:83-100. (Pubitemid 28272192)
45. Chu T. Molecular diagnosis of pancreas carcinoma. J Clin Lab Anal 1997;11:225-231. (Pubitemid 27282273)
46. Dillon D, Johnson C, Topazian M, Tallini G, Rimm D, Costa J. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms. Cancer J 2000;6:294-302.
47. Ito R, Tamura K, Ashida H, et al. Usefulness of Ki-ras gene mutation at codon 12 in bile for diagnosing biliary strictures. Int J Oncol 1998;12:1019-1023. (Pubitemid 28186760)
48. Itoi T, Ohyashiki K, Yahata N, et al. Detection of telomerase activity in exfoliated cancer cells obtained from bile. Int J Oncol 1999;15:1061-1067.
49. Iwao T, Hanada K, Tsuchida A, Hirata M, Eguchi N, Kajiyama G. The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens for pancreatic duct brushing with special attention to p53 mutations. Cancer 1998;82:1487-1494. (Pubitemid 28164994)
50. Laethem J, Bourgeois V, Parma J, et al. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases. Gastrointest Endosc 1998;47:479-485. (Pubitemid 28287566)
51. Morales C, Burdick J, Saboorian M, Wright W, Shay J. In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies. Gastrointest Endosc 1998;48:402-405. (Pubitemid 28463162)
52. Mu X, Brien T, Ross J, Lowry C, McKenna B. Telomerase activity in benign and malignant cytologic fluids. Cancer Cytopathol 1999;87:93-99. (Pubitemid 29204906)
53. Sakorafas G, Tsiotou A. Genetic basis of cancer of the pancreas: diagnostic and therapeutic applications. Eur J Surg 1994;160:529-534. (Pubitemid 24325836)
54. Stewart C, Burke G. Value of p53 Immunostaining in pancreatobiliary brush cytology specimens. Diagn Cytopathol 2000;23:308-313.
55. Sturm P, Hruban R, Ramsoekh T, et al. The potential use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol 1998;186:247-253. (Pubitemid 28494351)
56. Sturm P, Rauws E, Hruban R, et al. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis. Clin Cancer Res 1999;5:629-635. (Pubitemid 29131974)
57. Vasef M, Ross J, Cohen M. Telomerase activity in human solid tumors. Diagnostic utility and clinical applications. Am J Clin Pathol 1999;112(Suppl 1):S68-S75. (Pubitemid 30219465)
58. Abu-Elmagd K, Selby R, Iwatsuki S, et al. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993;25:1124-1125. (Pubitemid 23078922)
59. Ahrendt SA, Pitt HA, Kalloo AN, et al. Primary sclerosing cholangits: resect, dilate, or transplant? Ann Surg 1998;227:412-423.
60. Angulo P, Lindor K. Primary sclerosing cholangitis. Hepatology 1999;30:325-332. (Pubitemid 29300604)
61. Bergquist A, Glaumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998;27:311-316. (Pubitemid 28081041)
62. Gores G. Early detection and treatment of cholangiocarcinoma. Liver Transpl 2000;6:S30-S34.
63. Goss JA, Shackleton CR, Farmer DG, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997;225:472-483. (Pubitemid 28079096)
64. Harrison P. Prevention of bile duct cancer in primary sclerosing cholangitis. Ann Oncol 1999;10(Suppl 4):S208-S211. (Pubitemid 29333434)
65. Klompmaker I, Haagsma E, Verwer R, Jansen P, Slooff M. Primary Sclerosing Cholangitis and Liver Transplantation. Scand J Gastroenterol 1996;31 (Suppl 218):98-102. (Pubitemid 26261860)
66. Kornfeld D, Ekbom A, Ihre T. Survival and Risk of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis. A Population Based Study. Scand J Gastroenterol 1997;32:1042-45. (Pubitemid 27433668)
67. Leeuwen D, Reeders W. Primary sclerosing cholangitis and choloangiocarcinoma as a diagnostic and therapeutic dilemma. Ann Oncol 1999;10 (Suppl 4):S89-S93. (Pubitemid 29333404)
68. Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut 1991;32:1369-1373.
69. Nashan B, Schlitt H, Tusch G, et al. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology 1996;23:1105-1111. (Pubitemid 26137054)
70. Ponsioen C, Tytgat G. Primary sclerosing cholangitis: a clinical review. Am J Gastroenterol 1998;93:515-523. (Pubitemid 29080995)
71. Rosen C, Nagorney D. Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 1991;11:26-30.
72. Weisner R. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models. Mayo Clin Proc 1998;73:575-588.